Results 221 to 230 of about 256,905 (322)

Macrophage Activation Syndrome in Adult-Onset Still's Disease: Challenges in Early Detection and Management. [PDF]

Cureus
Regmi A, Hale C, Lin N, Kinduell KK, Ethiraj SK.   +4 more
europepmc   +1 more source

An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome

, 2014
Scott Canna, Adriana A. de Jesus, Sushanth Gouni, Stephen R. Brooks, Bernadette Marrero, Yin Liu, Michael A. DiMattia, Kristien J.M. Zaal, Gina A. Montealegre Sanchez, Hanna Kim, Dawn Chapelle, Nicole Plass, Yan Huang, Alejandro V. Villarino, Angélique Biancotto, Thomas A. Fleisher, Joseph A. Duncan, John J. O’Shea, Susanne M. Benseler, Alexei A. Grom, Zuoming Deng, Ronald M. Laxer, Raphaela Goldbach‐Mansky   +22 more
openalex   +1 more source

Successful Tocilizumab Therapy for Macrophage Activation Syndrome Associated with Adult-Onset Still’s Disease: A Case-Based Review [PDF]

, 2016
Eri Watanabe, Hitoshi Sugawara, Takeshi Yamashita, Akira Ishii, Aya Oda, Chihiro Terai   +5 more
openalex   +1 more source

Core Fucosylation Represses SMURF1‐Dependent Degradation of CD47 to Promote Tumor Immune Evasion

Advanced Science, EarlyView.
FUT8‐mediated core fucosylation of CD47 at N111 blocks SMURF1 binding and reduces CD47 ubiquitination and degradation. Blocking N111 glycosylation reduces CD47 expression and promotes macrophage phagocytosis of tumor cells. Furthermore, ablating CD47 core fucosylation boosts CD103+ dendritic cells (DCs) infiltration, increases natural killer (NK) cell ...
Yuting Cao, Siyuan Chai, Mingyang Li, Xiaoming Chen, Jiating Hu, Bingyi Lin, Liming Wu, Wen Yi, Qiang Zhu   +8 more
wiley   +1 more source

Macrophage activation syndrome successfully treated with eculizumab and emapalumab: a case report. [PDF]

Front Immunol
Faggioli P, Galeazzi M, Ferrari C, Capelli F, Marchesi C, Marchionni L, Castelnovo L, Tamburello A, Capparelli E, Campidelli C, Mazzone A.   +10 more
europepmc   +1 more source

[Clinical characteristics and treatment outcomes of macrophage activation syndrome in adults: A case series of 67 patients].

, 2019
Yao Hh, Wang Yn, X Zhang, Zhao Jx, Yanjie Jia, Z Wang, Li Zg   +6 more
openalex   +2 more sources

The Immune Microenvironment in Liver Cancer: From Analysis to Targeting

Advanced Science, EarlyView.
This review explores how smart nanomedicines overcome the immunosuppressive tumor microenvironment in liver cancer. It details targeted delivery strategies and immune reprogramming mechanisms, including remodeling abnormal physiology, modulating metabolism, and inducing immunogenic cell death. The article highlights the paradigm shift toward multimodal
Jiaming Lan, Hao Li, Jian Xue, Yourong Duan, Jin Sun, Meng Niu   +5 more
wiley   +1 more source

Life-Threatening Macrophage Activation Syndrome in Pregnancy: First Manifestation of SLE Induced by Parvovirus B19. [PDF]

Int J Mol Sci
Plavsic A, Miskovic R, Jovanovic D, Karic U, Jovicic Z, Radovic S, Drazic A, Dasic A, Arandjelovic S.   +8 more
europepmc   +1 more source

Hemofiltration in human sepsis [PDF]

, 1994
Deppisch, R., Faist, E., Hartl, W. H., Hoffmann, J. N., Inthorn, D., Jochum, Marianne   +5 more
core   +1 more source

RADA16 and SAAP148 Peptide‐Modified Collagen Self‐Assembled Hydrogels for Accelerated Healing of Infected Wounds

Advanced Science, EarlyView.
Collagen type I (Col I) is integrated with self‐assembling peptide RADA16 and loaded with anti‐bacterial peptide SAAP148 to develop a self‐assembled nano‐microstructure hydrogel (Col I‐RADA16‐SAAP148, CRS) without chemical cross‐linkers. CRS exhibits excellent mechanical properties, sustained SAAP148 release to inhibit bacterial infection, macrophage ...
Qian Liu, Jiawei Wu, Ho‐Pan Bei, Yufei Chen, Yifan Zhang, Xueliang Peng, Fulin Chen, Xin Zhao, Zhuoyue Chen   +8 more
wiley   +1 more source